INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung scarring drug studied in rare muscle disease patients
Disease control TerminatedThis study looked at whether the drug nintedanib is safe and tolerable for people with myositis (a muscle disease) that also causes lung scarring. It included 11 adults who were already on immune-suppressing medications. The goal was to see if adding nintedanib could help slow lu…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Hydroxychloroquine studied for rare childhood lung disease
Disease control TerminatedThis study tested whether hydroxychloroquine could help children with a rare lung condition called interstitial lung disease. About 35 children were enrolled, but the trial was stopped early. The goal was to see if the drug improved oxygen levels or breathing, but results are lim…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Matthias Griese • Aim: Disease control
Last updated May 05, 2026 11:55 UTC